Gaining Velocity

Velocity Pharmaceutical Development LLC thinks its investment partnership withRemeditex Ventureswill give it access to capital and regional deal networks without cluttering the boardroom with too many stakeholders.

The two firms teamed up to jointly evaluate late-stage preclinical and clinical-stage assets from pharma, biotech and academia. Velocity - a holding company funded by CMEA Capital - and Remeditex will co-invest to advance assets through Phase II proof of concept, after which programs will be out-licensed. Both partners can present opportunities for investment...